ESPR
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. (ESPR) has 17 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 13, 2026.
Insiders have net sold $240K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Sheldon L. Koenig
- Employees:294
- HQ:Ann Arbor, MI, US
- IPO:2013-06-26
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$240K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$818.6M
Price slightly stale
| Source | ||||||
|---|---|---|---|---|---|---|
Looker BenjaminFirst filing | Chief Legal Officer | Sale | 11,824 | $37K | Jun 18 | SEC ↗ |
Halladay BenjaminFirst filing | Chief Financial Officer | Sale | 10,773 | $34K | Jun 18 | SEC ↗ |
Koenig Sheldon L.First filing | President and CEO | Sale | 53,588 | $169K | Jun 18 | SEC ↗ |
Related companies
Esperion Therapeutics, Inc. is in the Healthcare sector.